Antimüllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception

AMH and AFC are significantly lower among women with recent exposure to HC. AMH and AFC should be interpreted with caution when measured in the setting of recent hormone use.